Recombinant DNA pharmaceuticals

Definition

Recombinant DNA pharmaceuticals are medications produced through the genetic engineering of organisms to express therapeutic proteins. These pharmaceuticals often include hormones, antibodies, and enzymes used in treating various diseases.

5 Must Know Facts For Your Next Test

1. The first recombinant DNA pharmaceutical approved by the FDA was human insulin produced by bacteria.
2. Recombinant DNA technology involves inserting a gene of interest into a vector, which is then introduced into a host organism for protein production.
3. Common hosts for producing recombinant pharmaceuticals include bacteria, yeast, and mammalian cells.
4. Recombinant DNA pharmaceuticals can be more consistent and safer than traditional methods of drug production.
5. This technology has enabled the development of treatments for conditions like diabetes (insulin), hemophilia (clotting factors), and cancers (monoclonal antibodies).

Related terms

Vector:

A vehicle used to transfer genetic material to a host cell.

Gene Cloning:

The process of making multiple copies of a specific gene.

Monoclonal Antibodies:

Antibodies produced from a single clone of cells that are identical and specific to one antigen.